QUOTE AND NEWS
Capital Essence's Investment Blog- 錢途集團 » Page not found  Apr 13  Comment 
with the S&P fast approaching record highs following last week’s rally, our near-term work on momentum and price pattern suggested that it’s a good time to take profits rather than join the buying in the hope of a prolonged uptrend.
Motley Fool  Apr 11  Comment 
Alkermes Plc's ALKS 3831 could help patients that take atypical antidepressants avoid gaining weight.
Forbes  Apr 8  Comment 
Pfizer, Eli Lilly and Bristol-Myers Squibb all sold cannabis at the turn of the century, but now want nothing to do with it.
Jutia Group  Apr 1  Comment 
[PR Newswire] - INDIANAPOLIS, April 1, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2015 on Thursday, April 23, 2015. Lilly will also conduct a conference ... Read more on...
FiercePharma  Mar 24  Comment 
The FDA says it won't recommend new limits on Eli Lilly schizophrenia med Zyprexa Relprevv after almost a year of investigating the deaths of two patients 3 to 4 days after they received injections.
Benzinga  Mar 23  Comment 
In a report published Monday, Cowen and Co analysts maintained an Outperform rating on Eli Lilly and Company (NYSE: LLY), while raising the price target from $78 to $85, after the release of BIIB037 data. In the report Cowen noted, "Several...
TheStreet.com  Mar 23  Comment 
NEW YORK (Real Money) -- Lilly  is moving further into new 52-week-high territory. The stock began this impressive move with a short-term trendline break a week ago. LLY got a big bump two days later with a news-inspired (Hanmi joint venture)...
TheStreet.com  Mar 23  Comment 
NEW YORK (TheStreet) -- Eli Lilly shares are up 1.32% to $77.12 in afternoon trading on Monday after the company announced that it would continue late-stage studies with Pfizer  for their chronic pain drug, tanezumab, after the Food and...
Jutia Group  Mar 23  Comment 
[Reuters] - The U.S. Food and Drug Administration said it would not recommend changes to the prescribing or use of Eli Lilly and Co's schizophrenia drug after a review of two deaths. Elevated levels of the drug, Zyprexa ... Read more on this. Eli...




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki